Truepill joined the Unicorn Club on October 28, 2021, after raising a $142 million Series D funding round led by TI Platform Management, valuing the company at $1.6 billion. Headquartered in Hayward, California, United States, Truepill provides an API-connected healthcare platform that enables users to search, select, and order medications, consult with doctors virtually, and receive prescriptions and deliveries. The company has raised a total of $322 million in funding and employs between 1,001 and 5,000 people (as of July 1, 2024).
Keep reading to learn how Truepill is revolutionizing digital pharmacy and healthcare delivery with its integrated telehealth and fulfilment infrastructure.
What Is Truepill and What Does It Do?
Founded in 2016, Truepill offers a digital pharmacy solution that integrates prescription processing, telemedicine, and medication delivery through an API‑driven platform. Users can place orders, access teleconsultations, and manage prescriptions through its app, which also supports reorder functionality and telehealth services.
Truepill’s platform serves payers, providers, and patients with a seamless end‑to‑end healthcare delivery experience.
How Much Funding Has Truepill Raised?
- Series D
- Amount Raised: $142M
- Date: October 28, 2021
- Lead Investor: TI Platform Management
- Valuation: $1.6B
- Purpose: Expand digital pharmacy services, scale telehealth integrations, and enhance nationwide fulfilment infrastructure.
- Series D Extension
- Amount Raised: $66.2M
- Date: August 30, 2023
- Lead Investors: Oak HC/FT, Optum Ventures
- Valuation: Undisclosed
- Purpose: Further product development, accelerate B2B partnerships with health plans and employers.
- Earlier Rounds (Seed to Series C)
- Cumulative Funding: ≈ $114M
- Key Investors: Sound Ventures, Oak HC/FT, Initialised Capital
- Purpose: Build a core pharmacy and telehealth platform, launch API services, and establish a fulfilment network.
Total Funding Raised: $322M
Latest Funding Date: August 30, 2023
Latest Valuation: $1.6B
Employee Count: 1,001–5,000 (as of July 1, 2024)
Key Investors
- Sound Ventures
- Details: Venture firm founded by Ashton Kutcher and Guy Oseary, investing in transformative tech and healthcare companies.
- Focus Areas: Digital health, consumer tech, and SaaS platforms.
- Oak HC/FT
- Details: Growth‑stage VC firm specializing in healthcare, fintech, and software infrastructure.
- Focus Areas: API‑driven healthcare platforms, digital pharmacy, and telemedicine.
- TI Platform Management
- Details: Investment firm focusing on technology and infrastructure opportunities across sectors.
- Focus Areas: Healthcare IT, platform scaling, and B2B SaaS.
Where Is Truepill’s Headquarters?
Truepill is headquartered in Hayward, California, United States, where it develops its telehealth and digital pharmacy platform, coordinates operations, development, and customer integrations, and supports nationwide fulfilment.
What’s Next for Truepill?
Truepill plans to deepen its integration with health plans, providers, and employer benefits programs by expanding its API capabilities, automating pharmacy fulfilment, and offering telehealth services.
The company aims to enhance its platform with advanced analytics, same‑day delivery partnerships, and international expansion to support more patients and payers.
Get Investor & Funding Insights with TexAu
TexAu provides verified investor and funding data for companies like Truepill. Explore insights on digital health, telemedicine infrastructure, and healthcare‑tech startups.
Sign up for Free on TexAu to access real‐time investor and funding intelligence.
